P635: AN UPDATE OF SAFETY AND EFFICACY RESULTS FROM PHASE 1 STUDY OF LP-108, A NOVEL AND SELECTIVE BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMAS

التفاصيل البيبلوغرافية
العنوان:	P635: AN UPDATE OF SAFETY AND EFFICACY RESULTS FROM PHASE 1 STUDY OF LP-108, A NOVEL AND SELECTIVE BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMAS
المؤلفون:	Wei Xu, Ru Feng, LI Wang, Huayuan Zhu, Keshu Zhou, Xiaorui Fu, Hongmei Jing, Yuqin Song, Junyuan Qi, Guohui Cui, Fei LI, Shaoyuan Wang, Hui Zhou, Wenbin Qian, Qingqing Cai, Xielan Zhao, Xutao Guo, Xiaolei Wei, Ningjing Lin, Zhongyuan Xu, Zheng Wang, Xiang Xiao, Jiale Dong, Yejiang Lou, Yue Shen, Yi Chen, Yu Chen, Fenlai Tan, Stephen Anthony, Jianyong LI
المصدر:	HemaSphere, Vol 7, p e324590c (2023)
بيانات النشر:	Wiley, 2023.
سنة النشر:	2023
المجموعة:	LCC:Diseases of the blood and blood-forming organs
مصطلحات موضوعية:	Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2572-9241
Relation:	http://journals.lww.com/10.1097/01.HS9.0000969444.32459.0c; https://doaj.org/toc/2572-9241
DOI:	10.1097/01.HS9.0000969444.32459.0c
URL الوصول:	https://doaj.org/article/a0d0914f61e74b97ab82c826d9893290
رقم الأكسشن:	edsdoj.0d0914f61e74b97ab82c826d9893290
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	25729241
DOI:	10.1097/01.HS9.0000969444.32459.0c